newsfilter
← Latest News
GlobeNewswire·

Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation

Company reduces the maximum aggregate payments under its royalty financing agreement from $125 million to $65 millionCompany accelerated payment of $42.6 million upfront, bringing total payments made to date to $50